The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
- Track 1-1Novel DDS for herbal formulations
- Track 1-2Recent advances in NDDS
- Track 1-3Application of NDDS
- Track 1-4NDDS devices & fabrication methods
- Track 1-5Drug delivery carriers, micelles & dendrimers
Respiratory infections represent a major global health problem. They are often treated by parenteral administrations of antimicrobials. Unfortunately, systemic therapies of high-dose antimicrobials can lead to severe adverse effects and this calls for a need to develop inhaled formulations that enable targeted drug delivery to the airways with minimal systemic drug exposure. Recent technological advances facilitate the development of inhaled anti-microbial therapies. Novel particle engineering and intelligent device design also make dry powder inhalers appealing for the delivery of high-dose antibiotics.
- Track 2-1Nasal & Pulmonary drug delivery
- Track 2-2Inhaled formulations for respiratory infections
- Track 2-3Formulation approaches and devices
- Track 2-4Current development in the evaluation methods of Pulmonary DDS
- Track 2-5Delivery devices
Pharmacotherapy can be characterized as the treatment and counteractive action of ailment and ailment by methods for medications of the synthetic or organic root. It positions among essential techniques for therapeutic treatment, together with surgery, physical therapy, radiation, and psychotherapy. Although it is practically difficult to appraise the correct degree of the effect of pharmacotherapy on human well-being, there can be almost certain that pharmacotherapy, together with enhanced sanitation, better-eating regimen, and better lodging, has improved individuals. Phenomenal advancements in genomics and atomic science today offer a plenty of new medication targets. The utilization of present-day concoction manufactured strategies empowers the blend of many medication hopefuls in shorter circumstances than at any other time.
- Track 3-1Application of NDDS in the pharmacotherapy of hyperlipidemia
- Track 3-2Controlled drug delivery: therapeutic and pharmacological aspects
- Track 3-3Impact of pharmacotherapy on DDS
- Track 3-4Pharmacokinetics, pharmacodynamics of drugs and new DDS
- Track 3-5Rational pharmacotherapy of the inner ear
For more than two decades, researchers have attempted to find a way to use the skin as a portal of entry for drugs to overcome problems associated with traditional modes of drug administration. This has been a complicated task due to the highly effective barrier properties of the skin. To deliver drugs through the skin, most compounds require various degrees of permeation enhancement. More recent research makes use of innovative vesicular carriers, electrically assisted delivery and various micro invasive methods, some incorporating technologies from other fields. These new and exciting methods for drug delivery are already increasing the number and quality of dermal and transdermal therapies.
- Track 4-1Transdermal drug delivery (TDDS)
- Track 4-2Cutaneous drug delivery
- Track 4-3Dermal & TDDS: Current & future prospects
- Track 4-4Dendrimer-mediated drug delivery to the skin
- Track 4-5Advances in the bioanalytical study of drug delivery across the skin
The use of nanotechnology in medicine and more specifically drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifically for cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. Recent years have witnessed unprecedented growth of research and applications in nanoscience and nanotechnology. Anticipated applications in medicine include drug delivery, both in vitro and in vivo diagnostics, nutraceuticals and production of improved biocompatible materials.
- Track 5-1Types of nanoparticles for CNS drug delivery
- Track 5-2Mechanisms for delivery
- Track 5-3Recent advances in nanoparticle-mediated drug delivery
- Track 5-4Nanotechnology in Therapeutics
- Track 5-5Nanotechnology in drug delivery
- Track 5-6Inorganic nanoparticles in drug delivery
Liposomes, which are biodegradable and essentially non-toxic vehicles, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery systems. In addition, liposomes can be used to carry radioactive compounds as radiotracers can be linked to multiple locations in liposomes. In the past two decades there have been major advances in the development of liposomal drug delivery systems suitable for applications ranging from cancer chemotherapy to gene therapy.
- Track 6-1Advances and challenges of liposome assisted drug delivery
- Track 6-2Liposomal DDS for targeted cancer therapy
- Track 6-3Targeted liposomal drug delivery
- Track 6-4Recent advances in liposomal drug delivery
- Track 6-5Liposomes as DDS for medical treatments
Drug transporters are now increasingly recognized as important determinants of variable drug disposition and response. In addition, transporter associated problems appear to be occurring with greater frequency during the drug discovery and development process. Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and brain, and play key roles in drug absorption, distribution, and excretion. The information on the functional characteristics of drug transporters provides important information to allow improvements in drug delivery or drug design by targeting specific transporter proteins.
- Track 7-1Drug delivery to target tissues using transporters
- Track 7-2Role of membrane transporters in DDS
- Track 7-3ATP - binding cassette (ABC) transporters
- Track 7-4Solute Carrier Transporter
- Track 7-5Ocular Transporters
Many drug targets are localized to particular subcellular compartments. Yet current drug design strategies are focused on bioavailability and tissue targeting and rarely address drug delivery to specific intracellular compartments. Insights into how the cell traffics its constituents to these different cellular locations could improve drug design. The process of the design/discovery of drugs typically involves understanding the character of targets (e.g. enzyme, cell, tissues, etc) related to the disease, setting-up the concept of drug design, providing lead compounds (via traditional medicines, natural products, biological macromolecules, compound libraries, computational chemistry, etc.), and design and lead optimization by means of analyzing structure-activity-relationships. A deep understanding of this process in addition to the mode of action at a molecular level will help pharmacists with decisions on appropriate dosing and administration of medicines.
- Track 8-1Designing Drug-Delivery Nanoparticles
- Track 8-2Drug Targeting strategies
- Track 8-3Recent approaches to drug targeting
- Track 8-4Computer aided drug design
- Track 8-5Rational drug design
Vaccines are the preparations given to patients to evoke immune responses leading to the production of antibodies (humoral) or cell-mediated responses that will combat infectious agents or noninfectious conditions such as malignancies. Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. However, the selectivity and specificity of sub-units of the causative organism like proteins, carbohydrates can be exploited for producing strong and prolonged immune responses by catering them to the immune system in such a way that a specific and strong immune response is induced.
- Track 9-1Liposomal vaccine delivery systems
- Track 9-2Oral vaccines
- Track 9-3Needle-free vaccine Delivery
- Track 9-4Mucosal vaccine delivery
- Track 9-5DNA vaccine delivery system
- Track 9-6Emulsion delivery systems
- Track 9-7Micellar delivery systems
- Track 9-8Dendrimer based delivery systems
- Track 9-9Jet injectors
- Track 9-10Polymeric nanoparticle delivery system
Preformulation is a group of studies that focus on the physicochemical properties of a new drug candidate that could affect the drug performance and the development of a dosage form. This could provide important information for formulation design or support the need for molecular modification. Every drug has intrinsic chemical and physical properties which has been consider before development of pharmaceutical formulation. This property provides the framework for drugs combination with pharmaceutical ingredients in the fabrication of dosage form. Objective of preformulation study is to develop the elegant, stable, effective and safe dosage form by establishing kinetic rate profile, compatibility with the other ingredients and establish physico-chemical parameter of new drug substances.
- Track 10-1Physiochemical properties of drugs
- Track 10-2Preformulation in drug discovery
- Track 10-3Preformulation in drug development
- Track 10-4Drug formulation considerations
- Track 10-5Freeze Drying
- Track 10-6Hot Melt Extrusion
In the past, our limited understanding of the processes involved in the initiation and growth of cancer hindered our ability to effectively treat most human malignancies and therapies were often associated with significant toxic side effects as well as re-emergence of disease. For years, chemotherapy has been a mainstay treatment option for inoperable cancers. The development of drug delivery systems such as liposomes has improved the specificity of various conventional anticancer agents by enhancing drug accumulation in tumours while often decreasing exposure to susceptible healthy tissues. More recently, the identification of a wide range of genes and corresponding protein products that are altered in various human cancers has revealed new molecular targets for cancer therapy that may provide improved selectivity for tumour cells over traditional cytotoxic agents.
- Track 11-1Nano-packages for anti-cancer drug delivery
- Track 11-2Liposomal DDS & anticancer drugs
- Track 11-3Applications of nanoparticles for anticancer drug delivery
- Track 11-4Targeted DDS for platinum-based anticancer drugs
- Track 11-5Challenges and strategies in anti-cancer nanomedicine development
The increasing use of biologics, a rise in the prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) are increasing the demand for safety syringes, prefilled syringes (PFS), and autoinjectors. Across the globe, the injectable route of drug administration is the most widely applied method of drug delivery after oral drug administration method. Growth in injectable drug delivery technologies market is likely to be hinged at China, India, Brazil, and Mexico in the coming years as the U.S. and European market reaches maturation. Growing incidence of cancer, and diabetes, rapid urbanization, improving healthcare infrastructure, and rising need for better technologies are pivotal factors driving the injectable drug delivery technologies market in these regions.
- Track 12-1Use of liposomes as injectable-DDS
- Track 12-2Needle-Free DDS
- Track 12-3Formulation packaging
- Track 12-4Needle stick protection and safety syringes
- Track 12-5Devices
Biopharmaceutical products are molecules that are the components of biological systems that are used in the treatment of human and animal health and disease. Formulation development of biopharmaceutical protein therapeutics. Production of biopharmaceutical involves many different, complex and lengthy steps which synthesis are, purification, formulation, final dosage preparation. Applications of biopharmaceuticals are agonist and antagonist of important receptors and enzymes, vaccines. The combination of biological molecules like antibodies with cytoxic compounds and agents, such as antibody drug used in cancer therapies.
- Track 13-1QA & QC of product
- Track 13-2Validation
- Track 13-3Methods used for drug formulation
- Track 13-4Drug formulation in pediatrics
Herbal formulation defines as a mean dosage form consisting of one or more herbs in specified quantities to provide specific nutritional, cosmetic benefits and used to treat, diagnose, mitigate diseases of human beings. Herbal drugs/herbal formulations are finished labelled products that contain active ingredients such as aerial or underground parts of plant or combinations whether in the crude state or as plant preparations. Herbal preparations are available in different forms including fresh, dried, in tablets, or capsules, or bottled in liquid form. Very rare pharmaceutical companies are involved in drug discovery screening from natural sources.
- Track 14-1Polyherbal formulation
- Track 14-2Herbal formulations for therapeutic applications
- Track 14-3Hypoglycemic effects of herbal drug formulations
- Track 14-4WHO guidelines
- Track 14-5Preparation of herbal medicines
Drug delivery is playing an increasingly significant role in the quest for new product opportunities as the pharmaceutical industry faces patent and pipeline challenges. Also, growing healthcare costs are shifting in-patient treatments to the home setting. As a result, injection delivery methods are on the rise, particularly for the treatment of chronic conditions. Improved methods for the development, manufacture, and administration of drugs, particularly increasingly complex biologics such as protein and peptide therapeutics, are more in demand than ever and are being met with advanced drug delivery options.
- Track 15-1Formulation and drug delivery technologies
- Track 15-2Trends in drug delivery
- Track 15-3New carriers in drug delivery
- Track 15-4Current approaches in the development of new systems
- Track 15-5Delivering drugs to brain via nasal spray
Drugs can be given to a person in a variety of formulations. Formulations is a mixture in a particular state that the drug is supplied to the patient. It can be either solid, semisolid or liquid formulations. The type of formulation given to a patient depends upon the type of patient and the condition of the patient (such as age, sex, and health condition). Also, the type of formulation is specific for particular routes of administration.
- Track 16-1Solid Formulations
- Track 16-2Liquid and semisolid formulations
- Track 16-3Pharmacokinetics & Pharmacodynamics
While the peptide and protein therapeutic market has developed significantly in the past decades, delivery has limited their use. Although oral delivery is preferred, most are currently delivered intravenously or subcutaneously due to degradation and limited absorption in the gastrointestinal tract. Due to rapid progress in biotechnology, as well as gene technology, the industry can produce many potential therapeutic peptides and proteins in commercial quantities. Endogenous proteins and peptides play an important role in the regulation and integration of life processes and act with high specificity and potency. Peptides and proteins have great potential as therapeutics. Currently, the market for peptide and protein drugs is estimated to be greater than US$40 billion/year, or 10% of the pharmaceutical market. This market is growing much faster than that of small molecules and will make up an even larger proportion of the market in the future.
- Track 17-1Recent advances in peptide and protein drug delivery
- Track 17-2Peptidal drug delivery
- Track 17-3Oral protein and peptide drug delivery
- Track 17-4Polymers for protein and peptide drug delivery
- Track 17-5Cell therapy
In the last few decades, advances in nanomedicine, biotechnology, chemistry and materials science have re-ignited scientific and industrial interest in drug delivery research in an exponential manner. Innovation is drug delivery is an important part in product lifecycle management as well as for product differentiation in new drug development. Facing greater challenges in bringing new molecular entities to market, the large pharma companies are seeking to capitalize on advances in drug delivery for a competitive advantage.
- Track 18-1Smart DDS
- Track 18-2Formulations for future cancer therapy
- Track 18-3Future scope for nanomaterials drug delivery
- Track 18-4New developments & technologies
- Track 18-5Hydrogels for future drug delivery
Biomaterials are widely used in numerous medical applications. Chemical engineering has played a central role in this research and development. Polymers as biomaterials, materials and approaches used in drug and protein delivery systems, materials used as scaffolds in tissue engineering, and nanotechnology and microfabrication techniques applied to biomaterials. Drug delivery systems have unusual materials requirements which derive mainly from their therapeutic role: to administer drugs over prolonged periods of time at rates that are independent of patient-to-patient variables. Selection of materials for such systems is further complicated by the need for compatibility with the drug contained within the system.
- Track 19-1Present and future applications of biomaterials
- Track 19-2Biomaterials for DDS
- Track 19-3Polymers as biomaterials for controlled drug delivery
- Track 19-4Biocompatible & biodegradable polymers
- Track 19-5Polymeric biomaterials for platinum-based anticancer drugs
Numerous new medications have been developed to effectively treat complicated conditions, but at the same time some of them produce severe side effects that the benefit does not always outweigh the risk. Some drugs have been proven to be very effective in vitro but cannot withstand the endogenous enzymes found within the gastrointestinal (GI) tract (if taken orally), deeming them nearly worthless in vivo. While incredible progress has been made in identifying drug targets, designing and making better drug molecules; there is still room to improve the drug delivery systems and targeting
- Track 20-1Controlled DDS in clinical disease management
- Track 20-2Current research in drug delivery
- Track 20-3Nanoparticles in the clinic
- Track 20-4Challenges of liposome assisted drug delivery
- Track 20-5Implantable drug delivery
- Track 20-6Drug delivery for brain tumour